Amniotic Tissue Allografts
Since 1910, amniotic membrane has been successfully used for skin grafting and for healing of various tissues including skin, cornea, and ligament in clinical settings. In addition to being nutrient-rich tissues with the ability to stimulate soft tissue development, amniotic membrane acts as an adhesion barrier and has demonstrated the ability to reduce inflammation, promote bone growth and cartilage repair. The tissue is immune privileged, speeds fibrogenesis and angiogenesis, and has demonstrated anti-scarring and anti-adhesive properties.
Live Cell Therapies
The amniotic fluid in RegeneFlow is used by physicians to protect, cushion, and lubricate joints, as well as to balance inflammation, moderate pain and promote healing.
RegeneFlow can be an excellent approach for patients seeking a non-steroidal option or who have reached the limit of steroid injections.
RegeneFlow is a human tissue allograft derived from amniotic fluid. The amniotic fluid is donated by mothers delivering healthy babies by scheduled Caesarean section and then post-processed and sterilized by a registered tissue bank.
RegeneFlow contains key growth, curative factors, and lubrication factors such as:
EGV - Epidermal Growth Factor
FGF - Fibroblast Growth Factor
HA - Hyaluronic Acid for lubrication and cushioning
IL-1Ra - Interleukin-1 Receptor Antagonis
PDGV - Platelet Derived Growth Factor A & B
TGF-βTransforming Growth Factor beta
TIMP-1 - Tissue Inhibitor of Metalloproteinases 1
TIMP-2 - Tissue Inhibitor of Metalloproteinases 2
VEGF - Vascular Endothelial Growth Factor